APORS Clinical Review Tool Data Summary FY18 – Performance # Records % in IDHS Report Data from APOR-HRIF Outcome Indicator # Expected # Completed Standard or State Reviewed Compliance Period IDHS Reports Average APORS 2-12 mos Subsequent APORS Visit APORS 13-24 mos With Infant: 80% HRIF 2-12 mos (2-5m, 6-8m, 10-14m, 16-20m, 22-25m) HRIF 13-24 mos Home Visit Report APORS 0-12 mos (SV02 by 12 months of 75% age. AS01 706 must HRIF 0-12 mos also be documented) APORS 3-12 mos Immunization Current APORS 13-24 mos (PA13 Imm Code, Date, 90% & Recommended Date HRIF 3-12 mos or PA14) HRIF 13-24 mos APORS 3-12 mos EPSDT Visits: APORS 13-24 mos SV01:806 at 4,6,12,18 80% HRIF 3-12 mos and 24 mos) HRIF 13-24 mos APORS 3-12 mos Developmental APORS 13-24 mos Screenings: 85% (SV01:824 at 2-6m, HRIF 3-12 mos 12m, 18m, 24 m) HRIF 13-24 mos
APORS Clinical Review Tool – Data Summary FY18 APOR-HRIF Outcome Indicator # Records Reviewed # Expected # Completed % in Compliance IDHS Report Period Data from IDHS Reports Performance Standard or State Average Subsequent APORS Visit With Infant: (2-5m, 6-8m, 10-14m, 16-20m, 22-25m) APORS 2-12 mos 80% APORS 13-24 mos HRIF 2-12 mos HRIF 13-24 mos Home Visit Report (SV02 by 12 months of age. AS01 706 must also be documented) APORS 0-12 mos 75% HRIF 0-12 mos Immunization Current (PA13 Imm Code, Date, & Recommended Date or PA14) APORS 3-12 mos 90% APORS 13-24 mos HRIF 3-12 mos HRIF 13-24 mos EPSDT Visits: SV01:806 at 4,6,12,18 and 24 mos) APORS 3-12 mos 80% APORS 13-24 mos HRIF 3-12 mos HRIF 13-24 mos Developmental Screenings: (SV01:824 at 2-6m, 12m, 18m, 24 m) APORS 3-12 mos 85% APORS 13-24 mos HRIF 3-12 mos HRIF 13-24 mos